MaxCyte, Inc. (MXCT)
0.8638
+0.02
(+2.02%)
USD |
NASDAQ |
May 07, 10:35
MaxCyte Cash from Investing (Quarterly) : 9.676M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| TELA Bio, Inc. | 0.192M |
| CONMED Corp. | 4.108M |
| Escalon Medical Corp. | 0.00 |
| IRIDEX Corp. | -0.106M |
| Electromed, Inc. | -0.656M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.689M |
| Cash from Financing (Quarterly) | 0.105M |
| Free Cash Flow | -36.18M |
| Free Cash Flow Per Share (Quarterly) | -0.0274 |
| Free Cash Flow to Equity (Quarterly) | -2.702M |
| Free Cash Flow to Firm (Quarterly) | -2.92M |
| Free Cash Flow Yield | -39.35% |